Media Influence on Funding for Breast Cancer Treatment
Author Information
Author(s): Christopher M Booth, George Dranitsaris, Gainford M Corona, Scott Berry, Michael Fralick, John Fralick, Joanna Sue, Mark Clemons
Primary Institution: National Cancer Institute of Canada Clinical Trials Group, Queen's University
Hypothesis
How does media coverage affect the funding decisions for anti-cancer agents like trastuzumab?
Conclusion
Media coverage significantly influences the priority-setting process for funding anti-cancer therapies.
Supporting Evidence
- 51 episodes of media coverage were identified for trastuzumab during the funding approval period.
- The median time to funding approval for trastuzumab was 3 months, compared to 31 months for other drugs.
- Trastuzumab received significantly more media attention than other anti-cancer therapies.
Takeaway
This study shows that when the media talks a lot about a cancer treatment, it can help that treatment get funded faster.
Methodology
A comprehensive search of media coverage related to trastuzumab and other anti-cancer drugs was conducted, analyzing the time to funding approval.
Potential Biases
Potential bias due to the influence of media portrayal on public perception and funding decisions.
Limitations
The study is descriptive and cannot quantify the exact influence of media or other external factors on funding decisions.
Participant Demographics
The study focuses on anti-cancer agents in Ontario, Canada.
Statistical Information
P-Value
0.56
Confidence Interval
95%CI: -.84 to 0.23
Statistical Significance
p = 0.56
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website